Stereoselective effects-of 2,3-benzodiazepines in vivo: electrophysiology and neuroprotection studies (Q73168967)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9076747%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

title

Stereoselective effects-of 2,3-benzodiazepines in vivo: electrophysiology and neuroprotection studies (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9076747%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

1 reference

1 reference

D Lodge

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9076747%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

A Bond

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9076747%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

M J O'Neill

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9076747%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

C A Hicks

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9076747%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

M G Jones

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9076747%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

publication date

1 January 1996

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9076747%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9076747%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

volume

35

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9076747%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

issue

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9076747%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

page(s)

1681-1688

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9076747%20AND%20SRC:MED&resulttype=core&format=json

The dissociative anaesthetics, ketamine and phencyclidine, selectively reduce excitation of central mammalian neurones by N-methyl-aspartate

1 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2896%2900155-4

GYKI 52466 blocks the increase in extracellular glutamate induced by ischaemia.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2896%2900155-4

Activity of 2,3-benzodiazepines at native rat and recombinant human glutamate receptors in vitro: stereospecificity and selectivity profiles

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2896%2900155-4

Blockade of the AMPA receptor prevents CA1 hippocampal injury following severe but transient forebrain ischemia in adult rats.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2896%2900155-4

Neuroprotective effect of the AMPA receptor antagonist LY-293558 in focal cerebral ischemia in the cat.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2896%2900155-4

The anticonvulsant effect of the non-NMDA antagonists, NBQX and GYKI 52466, in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2896%2900155-4

Protection against ischemic hippocampal CA1 damage in the rat with a new non-NMDA antagonist, NBQX

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2896%2900155-4

Excitatory amino acid receptors in epilepsy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2896%2900155-4

GYKI 52466, a 2,3-benzodiazepine, is a highly selective, noncompetitive antagonist of AMPA/kainate receptor responses.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2896%2900155-4

Systemic administration of MK-801 protects against ischemia-induced hippocampal neurodegeneration in the gerbil.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2896%2900155-4

MK-801 is neuroprotective in gerbils when administered during the post-ischaemic period

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2896%2900155-4

The neuroprotective effects of the decahydroisoquinoline, LY 215490; a novel AMPA antagonist in focal ischaemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2896%2900155-4

The neuroprotective actions of 2,3-dihydroxy-6-nitro-7-sulfamoyl-benzo(F)quinoxaline (NBQX) in a rat focal ischaemia model

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2896%2900155-4

Protection against post-ischemic behavioral pathology by the α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) antagonist 2,3-dihydroxy-6-nitro-7-sulfamoyl-benzo(f)quinoxaline (NBQX) in the gerbil

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2896%2900155-4

The non-NMDA antagonists, NBQX and GYKI 52466, protect against cortical and striatal cell loss following transient global ischaemia in the rat

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2896%2900155-4

Treatment with an AMPA antagonist 12 hours following severe normothermic forebrain ischemia prevents CA1 neuronal injury

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2896%2900155-4

Excitatory amino acids: new tools for old stories or pharmacological subtypes of glutamate receptors: electrophysiological studies.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2896%2900155-4

Effects of the non-NMDA antagonists NBQX and the 2,3-benzodiazepine GYKI 52466 on different seizure types in mice: comparison with diazepam and interactions with flumazenil

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2896%2900155-4

Excitatory amino acid neurotoxicity and neurodegenerative disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2896%2900155-4

GYKI 52466 antagonizes glutamate responses but not NMDA and kainate responses in rat abducens motoneurones

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2896%2900155-4

Therapeutic potential of excitatory amino acid antagonists: channel blockers and 2,3-benzodiazepines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2896%2900155-4

2,3-Dihydroxy-6-nitro-7-sulfamoyl-benzo(F)quinoxaline: a neuroprotectant for cerebral ischemia.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2896%2900155-4

AMPA, but not NMDA, receptor antagonism is neuroprotective in gerbil global ischaemia, even when delayed 24 h.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2896%2900155-4

Cerebroprotective effect of a non-N-methyl-D-aspartate antagonist, GYKI 52466, after focal ischemia in the rat

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2896%2900155-4

The non-N-methyl-D-aspartate receptor antagonists, GYKI 52466 and NBQX are anticonvulsant in two animal models of reflex epilepsy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2896%2900155-4

Electrophysiological studies with a 2,3-benzodiazepine muscle relaxant: GYKI 52466.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2896%2900155-4

Structure-activity relationships in the development of excitatory amino acid receptor agonists and competitive antagonists

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2896%2900155-4

Delayed treatment with AMPA, but not NMDA, antagonists reduces neocortical infarction.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2896%2900155-4

Anticonvulsant activity of AMPA/kainate antagonists: comparison of GYKI 52466 and NBOX in maximal electroshock and chemoconvulsant seizure models

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2896%2900155-4

10.1016/S0028-3908(96)00155-4

7 January 2021

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9076747%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

1 reference